FHL2 and cancer: To determine whether the FHL2-GLI2 fusion gene would constitute a pathognomonic genetic alteration for SSTs, we investigated the presence of the FHL2-GLI2 and the DYNLL1-GLI2 fusions in other sex cord-stromal tumors by RT-PCR and FISH, and across 33 common cancer types from The Cancer Genome Atlas (TCGA) retrieved from the Tumor Fusion Gene Data Portal28.